Device-related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-term Follow-up: the PRAETORIAN-XL Trial.
Olde Nordkamp LRA. et al, (2025), Circulation
Real-time Smartphone Alerts During Atrial Fibrillation Episodes with Implantable Cardiac Monitors and Wearable Devices: SMART-ALERT study.
Briosa E Gala A. et al, (2025), Heart Rhythm
Identifying extra pulmonary vein targets for persistent atrial fibrillation ablation: bridging advanced and conventional mapping techniques.
Sharp AJ. et al, (2025), Europace, 27
Granger causality connectivity analysis of persistent atrial fibrillation dynamics reveals posterior wall mechanistic insights
Barker J. et al, (2025), Heart Rhythm O2
Multi-modal integration of MRI and global chamber charge density mapping for the evaluation of atrial fibrillation.
Sharp AJ. et al, (2025), R Soc Open Sci, 12
Pain after subcutaneous implantable cardioverter-defibrillator implantation: A secondary analysis of the PRAETORIAN-DFT trial
de Veld JA. et al, (2025), Heart Rhythm O2
Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial.
Olde Nordkamp LRA. et al, (2024), Circ Arrhythm Electrophysiol
Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial.
Knops RE. et al, (2024), Circ Cardiovasc Qual Outcomes, 17
"Real-world" performance of the Confirm Rx™ SharpSense AF detection algorithm: UK Confirm Rx study.
Gala ABE. et al, (2024), J Arrhythm, 40, 1093 - 1101
Role of impedance drop and lesion size index (LSI) to guide catheter ablation for atrial fibrillation.
Leo M. et al, (2024), Pacing Clin Electrophysiol, 47, 1404 - 1411
The effect of sodium-glucose co-transporter 2 inhibitors on outcomes after cardiac resynchronization therapy.
Bray JJH. et al, (2024), ESC Heart Fail, 11, 2314 - 2322
Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure.
Singh JP. et al, (2024), JAMA Cardiol
Leveraging 3D Atrial Geometry for the Evaluation of Atrial Fibrillation: A Comprehensive Review.
Sharp AJ. et al, (2024), J Clin Med, 13
Left Atrial Appendage Occlusion: British Cardiovascular Intervention Society and British Heart Rhythm Society Position Statement
Betts TR. et al, (2024), Arrhythmia & Electrophysiology Review, 13
Left Atrial Appendage Occlusion: British Cardiovascular Intervention Society and British Heart Rhythm Society Position Statement
Betts TR. et al, (2024), Interventional Cardiology: Reviews, Research, Resources, 19
Cardiac resynchronization using fusion pacing during exercise.
Green PG. et al, (2023), J Cardiovasc Electrophysiol
What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria.
Dasí A. et al, (2023), J Physiol, 601, 4013 - 4032